Quick Answer
IRIDEX CORP reported Total Revenue of $48.67 million for fiscal year 2024.
IRIDEX CORP — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $48.67M -6.2% |
$51.87M -9.0% |
$56.97M +5.7% |
$53.90M +48.3% |
$36.35M -16.3% |
$43.45M +2.0% |
| Revenue (ASC 606) | $48.67M -6.2% |
$51.87M -9.0% |
$56.97M +5.7% |
$53.90M +48.3% |
$36.35M -16.3% |
$43.45M +2.0% |
| Net Income | -$8.91M +6.9% |
-$9.57M -26.8% |
-$7.55M -44.4% |
-$5.22M +17.4% |
-$6.33M +28.2% |
-$8.81M +31.2% |
| Diluted EPS | -$0.54 +8.5% |
-$0.59 -25.5% |
-$0.47 -38.2% |
-$0.34 +26.1% |
-$0.46 +28.1% |
-$0.64 +39.0% |
| Total Assets | $29.14M -15.4% |
$34.44M -18.6% |
$42.29M -13.1% |
$48.69M +74.1% |
$27.97M -19.7% |
$34.81M -16.5% |
| Cash and Equivalents | $2.39M -66.1% |
$7.03M -49.5% |
$13.92M -41.6% |
$23.85M +105.2% |
$11.63M -8.1% |
$12.65M -40.3% |
| Long-Term Debt | — | — | — | — | $1.25M | — |
| Stockholders Equity | $2.10M -78.0% |
$9.52M -44.7% |
$17.23M -26.0% |
$23.30M +34.2% |
$17.37M -23.5% |
$22.70M -24.2% |
| R&D Expense | $5.45M -20.2% |
$6.83M -4.8% |
$7.17M +4.5% |
$6.87M +109.3% |
$3.28M -10.9% |
$3.68M -8.1% |
| Operating Income | -$8.30M +17.0% |
-$10.01M -32.7% |
-$7.54M -0.1% |
-$7.53M -14.4% |
-$6.58M +26.6% |
-$8.97M +30.3% |
| Gross Profit | $19.50M -10.6% |
$21.81M -14.0% |
$25.37M +11.1% |
$22.83M +46.7% |
$15.56M -13.3% |
$17.94M +2.7% |
| Shares Outstanding | 16.64M +2.4% |
16.25M +1.6% |
15.99M +0.7% |
15.88M +14.2% |
13.90M +0.8% |
13.79M +1.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $12.48M | +7.8% | -8.0% |
| Revenue (ASC 606) | September 30, 2025 | $12.48M | +7.8% | -8.0% |
| Net Income | September 30, 2025 | -$1.57M | +18.6% | -58.2% |
| Diluted EPS | September 30, 2025 | -$0.09 | +25.0% | -50.0% |
| Total Assets | September 30, 2025 | $28.35M | -6.0% | -10.2% |
| Cash and Equivalents | September 30, 2025 | $5.57M | +44.4% | -17.8% |
| Long-Term Debt | March 31, 2021 | $312.0K | — | -75.0% |
| Stockholders Equity | September 30, 2025 | $4.68M | +78.5% | -22.7% |
| R&D Expense | September 30, 2025 | $972.0K | -25.2% | +11.6% |
| Operating Income | September 30, 2025 | -$1.41M | +24.5% | -50.1% |
| Gross Profit | September 30, 2025 | $4.01M | -7.2% | -14.3% |
| Shares Outstanding | September 30, 2025 | 17.05M | +2.5% | +1.4% |
- IRIDEX CORP reported Total Revenue of $48.67 million for fiscal year 2024.
- IRIDEX CORP showed a decrease of -6.2% in Total Revenue compared to the prior fiscal year.
- IRIDEX CORP reported Revenue (ASC 606) of $48.67 million for fiscal year 2024.
- IRIDEX CORP showed a decrease of -6.2% in Revenue (ASC 606) compared to the prior fiscal year.
- IRIDEX CORP reported Net Income of -$8.91 million for fiscal year 2024.
- IRIDEX CORP showed an increase of +6.9% in Net Income compared to the prior fiscal year.
- IRIDEX CORP reported Diluted EPS of $0.54 per share (loss) for fiscal year 2024.
- IRIDEX CORP showed an increase of +8.5% in Diluted EPS compared to the prior fiscal year.
- IRIDEX CORP reported Total Assets of $29.14 million for fiscal year 2024.
- IRIDEX CORP showed a decrease of -15.4% in Total Assets compared to the prior fiscal year.
- IRIDEX CORP reported Cash and Equivalents of $2.39 million for fiscal year 2024.
- IRIDEX CORP showed a decrease of -66.1% in Cash and Equivalents compared to the prior fiscal year.
- IRIDEX CORP reported Long-Term Debt of $1.25 million for fiscal year 2020.
- IRIDEX CORP reported Stockholders Equity of $2.10 million for fiscal year 2024.
- IRIDEX CORP showed a decrease of -78.0% in Stockholders Equity compared to the prior fiscal year.
- IRIDEX CORP reported R&D Expense of $5.45 million for fiscal year 2024.
- IRIDEX CORP showed a decrease of -20.2% in R&D Expense compared to the prior fiscal year.
- IRIDEX CORP reported Operating Income of -$8.30 million for fiscal year 2024.
- IRIDEX CORP showed an increase of +17.0% in Operating Income compared to the prior fiscal year.
- IRIDEX CORP reported Gross Profit of $19.50 million for fiscal year 2024.
- IRIDEX CORP showed a decrease of -10.6% in Gross Profit compared to the prior fiscal year.
- IRIDEX CORP reported Shares Outstanding of 16.64 million shares for fiscal year 2024.
- IRIDEX CORP showed an increase of +2.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: